Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1989 1
1993 1
1995 2
1997 1
1998 1
1999 1
2000 5
2001 2
2002 4
2003 3
2004 3
2005 3
2006 5
2007 3
2008 1
2009 2
2010 2
2011 6
2012 4
2013 7
2014 7
2015 7
2016 4
2017 5
2018 14
2019 5
2020 3
2021 4
2022 3
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

103 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Recurrent Primary Cutaneous Lymphoma"
Page 1
Extranodal Diffuse Large B Cell Lymphoma: Molecular Features, Prognosis, and Risk of Central Nervous System Recurrence.
Ollila TA, Olszewski AJ. Ollila TA, et al. Curr Treat Options Oncol. 2018 Jun 21;19(8):38. doi: 10.1007/s11864-018-0555-8. Curr Treat Options Oncol. 2018. PMID: 29931605 Free PMC article. Review.
Its prognosis and risk of recurrence in the central nervous system (CNS) vary according to the primary site of origin. ...These biologic features, which resemble primary CNS lymphoma, may underlie their stage-independent propensity for CNS involvement. …
Its prognosis and risk of recurrence in the central nervous system (CNS) vary according to the primary site of origin. ...Thes …
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial.
Kim YH, Bagot M, Pinter-Brown L, Rook AH, Porcu P, Horwitz SM, Whittaker S, Tokura Y, Vermeer M, Zinzani PL, Sokol L, Morris S, Kim EJ, Ortiz-Romero PL, Eradat H, Scarisbrick J, Tsianakas A, Elmets C, Dalle S, Fisher DC, Halwani A, Poligone B, Greer J, Fierro MT, Khot A, Moskowitz AJ, Musiek A, Shustov A, Pro B, Geskin LJ, Dwyer K, Moriya J, Leoni M, Humphrey JS, Hudgens S, Grebennik DO, Tobinai K, Duvic M; MAVORIC Investigators. Kim YH, et al. Lancet Oncol. 2018 Sep;19(9):1192-1204. doi: 10.1016/S1470-2045(18)30379-6. Epub 2018 Aug 9. Lancet Oncol. 2018. PMID: 30100375 Free article. Clinical Trial.
Patients were randomly assigned (1:1) using an interactive voice web response system to mogamulizumab (1.0 mg/kg intravenously on a weekly basis for the first 28-day cycle, then on days 1 and 15 of subsequent cycles) or vorinostat (400 mg daily). Stratification was by cutaneou …
Patients were randomly assigned (1:1) using an interactive voice web response system to mogamulizumab (1.0 mg/kg intravenously on a weekly b …
Management of malignant cutaneous wounds in oncologic patients.
Starace M, Carpanese MA, Pampaloni F, Dika E, Pileri A, Rubino D, Alessandrini A, Zamagni C, Baraldi C, Misciali C, Patrizi A, Bianchi T, Apalla Z, Piraccini BM. Starace M, et al. Support Care Cancer. 2022 Sep;30(9):7615-7623. doi: 10.1007/s00520-022-07194-0. Epub 2022 Jun 8. Support Care Cancer. 2022. PMID: 35672478 Free PMC article.
Complete healing of the wound, following the parallel complete remission of the lymphoproliferative neoplasia, was observed in one individual. Among the others, one died because of breast cancer, while cutaneous lesions in 2 individuals deteriorated after 1 year of …
Complete healing of the wound, following the parallel complete remission of the lymphoproliferative neoplasia, was observed in one in …
Rituximab Treatment of Primary Cutaneous Follicle Center Lymphoma: A Retrospective Review.
Wang S, Perlmutter JW, Johnston J, Nugent Z, Wiseman M. Wang S, et al. J Cutan Med Surg. 2022 Nov-Dec;26(6):604-612. doi: 10.1177/12034754221126119. Epub 2022 Sep 22. J Cutan Med Surg. 2022. PMID: 36134749 Free PMC article. Review.
BACKGROUND: Primary cutaneous B-cell lymphoma (PCBCL) presents only in the skin at the time of diagnosis with no evidence of extracutaneous disease, and primary cutaneous follicle center lymphoma (PCFCL) is the most common subtype. ...RES …
BACKGROUND: Primary cutaneous B-cell lymphoma (PCBCL) presents only in the skin at the time of diagnosis with no eviden …
Primary cutaneous B-cell lymphoma: A single-center 5-year experience.
Jacob LA, Asati V, Lakshmaiah KC, Govind BK, Lokanatha D, Babu SM, Lokesh KN, Rudresh AH, Rajeev LK, Mulchandani NJ, Anand A, Koppaka D, Mysore SN. Jacob LA, et al. Indian J Cancer. 2018 Apr-Jun;55(2):134-137. doi: 10.4103/ijc.IJC_418_17. Indian J Cancer. 2018. PMID: 30604723 Free article.
BACKGROUND: Skin is the second most common site for extranodal non-Hodgkin's lymphoma (NHL). Most primary cutaneous NHLs are of T-cell origin (70%). ...Two patients had primary cutaneous follicle center lymphoma, whereas the …
BACKGROUND: Skin is the second most common site for extranodal non-Hodgkin's lymphoma (NHL). Most primary cutaneous NHL …
Outcomes in primary cutaneous diffuse large B-cell lymphoma, leg type.
Kraft RM, Ansell SM, Villasboas JC, Bennani NN, Wang Y, Habermann TM, Thanarajasingam G, Lester SC, Macon W, Inwards DJ, Porrata LF, Micallef IN, Witzig TE, Thompson CA, Johnston PB, Nowakowski GS, Lin Y, Paludo J. Kraft RM, et al. Hematol Oncol. 2021 Dec;39(5):658-663. doi: 10.1002/hon.2919. Epub 2021 Aug 28. Hematol Oncol. 2021. PMID: 34453851
Primary cutaneous diffuse large B-cell lymphoma, leg type (PCDLBCL, LT) is a rare, aggressive lymphoma characterized by skin involvement predominantly in the lower extremities. ...ICIs may have a role in treating relapsed/refractory disease as reasonab …
Primary cutaneous diffuse large B-cell lymphoma, leg type (PCDLBCL, LT) is a rare, aggressive lymphoma character …
Primary cutaneous B-cell lymphoma: review and current concepts.
Pandolfino TL, Siegel RS, Kuzel TM, Rosen ST, Guitart J. Pandolfino TL, et al. J Clin Oncol. 2000 May;18(10):2152-68. doi: 10.1200/JCO.2000.18.10.2152. J Clin Oncol. 2000. PMID: 10811681 Review.
PURPOSE: Primary cutaneous B-cell lymphoma (PCBCL) has only recently been recognized as a distinct clinical entity. ...Although local cutaneous recurrences are observed in 25% to 68% of patients, dissemination to internal organs is rare. …
PURPOSE: Primary cutaneous B-cell lymphoma (PCBCL) has only recently been recognized as a distinct clinical entity. ... …
Outcomes of radiation therapy of indolent cutaneous B-cell lymphomas and literature review.
Gauci ML, Quero L, Ram-Wolff C, Guillerm S, M'Barek B, Lebbé C, Bagot M, Hennequin C. Gauci ML, et al. J Eur Acad Dermatol Venereol. 2018 Oct;32(10):1668-1673. doi: 10.1111/jdv.14972. Epub 2018 May 18. J Eur Acad Dermatol Venereol. 2018. PMID: 29578630 Review.
BACKGROUND: Primary cutaneous B-cell lymphomas represent approximately 25% of primary cutaneous lymphomas. ...CONCLUSION: This study confirms the good risk-benefit of radiotherapy for the treatment of primary cutaneous indolent B-cell lym …
BACKGROUND: Primary cutaneous B-cell lymphomas represent approximately 25% of primary cutaneous lymphomas. ...CO …
Systemic and primary cutaneous anaplastic large cell lymphomas.
Kadin ME, Carpenter C. Kadin ME, et al. Semin Hematol. 2003 Jul;40(3):244-56. doi: 10.1016/s0037-1963(03)00138-0. Semin Hematol. 2003. PMID: 12876673 Review.
Anaplastic large cell lymphoma (ALCL) is a neoplasm of activated lymphocytes, commonly expressing T-cell antigens and cytotoxic proteins. ...Excision or local irradiation is usually effective treatment. A clinically benign variant of primary cutaneo …
Anaplastic large cell lymphoma (ALCL) is a neoplasm of activated lymphocytes, commonly expressing T-cell antigens and c …
Clinical characteristics, differential diagnosis, and treatment outcome of subcutaneous panniculitis-like T-cell lymphoma: a literature review of published Japanese cases.
Ohtsuka M, Miura T, Yamamoto T. Ohtsuka M, et al. Eur J Dermatol. 2017 Feb 1;27(1):34-41. doi: 10.1684/ejd.2016.2914. Eur J Dermatol. 2017. PMID: 28120776 Review.
BACKGROUND: Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a rare subtype of non-Hodgkin lymphoma that shows phenotypic features of cytotoxic T cells and preferentially involves subcutaneous tissue. ...Further investigations are needed to bo …
BACKGROUND: Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a rare subtype of non-Hodgkin lymphoma tha …
103 results